Definitive Contract W9113M09C0156

The Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response awarded a $79,947,200.00 Firm Fixed Price contract to Elusys Therapeutics Inc. for the manufacture and vendor managed inventory of Anthim (obiltoxaximab) 600mg/6ml for Injection, an FDA-approved anthrax antitoxin. The contract has a period of performance from August 6, 2021 through September 14, 2024, and includes options for additional manufacturing and delivery of finished drug...

This federal contract award was made by the National Institute of Allergy and Infectious Diseases (NIAID), which is part of the U.S. Department of Health and Human Services, to Spring Valley Laboratories, Inc. for the provision of custom polyclonal antibody, polyclonal from exsanguination, and courier charges. The contract, valued at $3,557.61, was awarded on December 18, 2012 with a completion date of December 21, 2012. The contract type is a purchase order with a firm fixed price. There was no...

This is a firm-fixed price delivery order contract awarded by the Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response to Elusys Therapeutics Inc., a self-certified small disadvantaged business. The contract, valued at $24,501,100.00, is for "ANTHIM LETTER CONTRACT" and "FOR OTHER FUNCTIONS" services in the area of biomedical research and development. The contract has no set-aside designation and the period of...

<p>The federal contract award HHSN272201401008P was granted to Hycult Biotech Inc. by the National Institute of Allergy and Infectious Diseases (NIAID), a division of the Department of Health and Human Services. The contract is for the delivery of antibodies, valued at $3,346.75 on a firm fixed price basis. The contract was awarded on September 3, 2014 with an ultimate completion date of October 3, 2014. The contract does not have a set-aside designation.</p>

This is a firm fixed price delivery order awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian agency under the Department of Health and Human Services (HHS), to Emergent Manufacturing Operations Baltimore LLC, a for-profit manufacturer of medical countermeasures. The $196,434,000 award is for the provision of anthrax antitoxins to treat inhalational anthrax, under the agency's medical countermeasures development and procurement program. The...

This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to Creative Dynamics, Inc. (DBA Creative Biolabs) for the acquisition of recombinant human anti-influenza A virus (IAV) antibody in a 5mg quantity. The contract has a ceiling value of $7,960.00 and was awarded on October 31, 2017, with a planned completion date of January 31, 2018. This contract does not...

The U.S. Department of the Army Acquisition Support Center Joint PEO Chemical and Biological Defense awarded a $41,801,810.00 firm fixed-price delivery order contract to Emergent Biodefense Operations Lansing LLC, doing business as Emergent Biodefense, for the procurement of BioThrax (Anthrax Vaccine Adsorbed). This contract, which is not a set-aside, has an ultimate completion date of September 30, 2025. Emergent Biodefense is the prime contractor and manufacturer of BioThrax, the only...

<p>This is a Cost Plus Fixed Fee contract awarded by the Office of the Assistant Secretary for Preparedness and Response, a civilian agency, to Altimmune, Inc. for the development of a single-dose intranasal vaccine for post-exposure prophylaxis of inhalation anthrax. The award has a ceiling value of $135,880,962.00 and a period of performance through December 31, 2021. The contract was awarded on July 27, 2016 and does not have a set-aside designation.</p>

The U.S. Department of Health and Human Services (HHS) National Institute of Allergy and Infectious Diseases (NIAID) awarded a $4,657.20 firm fixed-price purchase order to Ebioscience, Inc., a subsidiary of Affymetrix, Inc., for the supply of monoclonal antibodies, including shipping charges. The contract, which does not have a set-aside designation, was awarded on September 11, 2011, with a completion date of September 19, 2012. This standing order is likely part of NIAID's broader efforts to...

This is a $180,000 fixed-price purchase order awarded by the Defense Health Agency (DHA) to Genovac Antibody Discovery LLC, a small disadvantaged business, to provide human monoclonal antibody (mAb) development services. The contract supports the Walter Reed Army Institute of Research (WRAIR) and Armed Forces Research Institute of Medical Sciences (WRAIR-AFRIMS) and includes performing feasibility studies, developing and producing a panel of fully human mAbs, and shipping the mAbs to AFRIMS...